生技智慧財產權（IP）貨幣化平台市場規模、佔有率和成長分析：按平台類型、部署模式、應用、最終用戶和地區分類－2026-2033年產業預測

2024 年全球生技智慧財產權 (IP) 貨幣化平台市場價值為 10.6 億美元，預計到 2025 年將成長至 12.8 億美元，到 2033 年將成長至 56.4 億美元，在預測期（2026-2033 年）內複合年成長率為 20.4%。

全球生物技術智慧財產權（IP）貨幣化平台市場構成了一個生態系統，支持專利持有人、研究機構和新創公司利用線上工具進行智慧財產權的授權和銷售。隨著藥物研發成本的不斷攀升，創新者尋求儘早創造資產價值，該市場的重要性日益凸顯。該領域最初起源於技術轉移辦公室，隨著雲端市場的興起而迅速發展。這些雲端市場引入了自動化估值方法，簡化了交易流程，並擴大了潛在的被授權者群體。授權模式與跨境研發需求的整合推動了這一成長，使製藥公司能夠將治療需求與專利發明連結起來，並提高交易效率。此外，人工智慧驅動的區塊鏈解決方案透過提供透明和自動化的流程，正在變革專利管理，從而創造一個更具活力和吸引力的市場。

全球生物技術智慧財產權（IP）貨幣化平台市場的促進因素

全球生物技術智慧財產權（IP）貨幣化平台市場的主要促進因素之一是日益嚴峻的全球健康挑戰所帶來的對創新醫療解決方案的不斷成長的需求。隨著生物技術研究的不斷發展，企業需要透過有效的商業化戰略來保護其智慧財產權。這種將突破性發現貨幣化的壓力促使生物技術公司尋求強大的平台，以便授權、出售或合作開發其專利和技術。此外，個人化醫療的興起以及基因組學和治療學的進步進一步凸顯了確保從智慧財產權資產中獲取收益的必要性，從而推動了此類平台的應用。

全球生物技術智慧財產權（IP）貨幣化平台市場的限制因素

全球生物技術智慧財產權貨幣化平台市場的主要限制因素之一是智慧財產權法規和合規要求的日益複雜化。隨著生物技術創新的不斷推進，圍繞專利和智慧財產權的法律環境也日益複雜。對於尋求將創新成果貨幣化的公司而言，應對這些法律規範可能既耗時又昂貴。此外，各國法律和執法機制的差異會阻礙跨國交易，並造成不確定性抑制對生技計畫的投資。這種複雜性會限制知識產權貨幣化平台的存取和吸引力，最終影響市場成長和存取。

全球生物技術智慧財產權（IP）貨幣化平台市場趨勢

全球生技智慧財產權（IP）貨幣化平台市場正經歷著向人工智慧驅動的投資組合估值策略的顯著轉變。生物技術公司正在利用先進的人工智慧演算法來提升其專利資產的價值，簡化高價值創新技術的識別流程，並最佳化授權談判。這些人工智慧工具能夠透過熟練地分析複雜的科學文獻、追蹤新興療法以及評估市場興趣，幫助企業根據未來趨勢對智慧財產權進行策略性優先排序。因此，具備人工智慧分析能力的平台提供者正在改變市場格局，創新者尋求有效的貨幣化途徑，投資者則探索獨特的研發管線機會，這些平台提供者的需求日益成長。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球生物技術知識產權（IP）貨幣化平台市場規模：按平台類型分類

• 授權平台
• IP市場平台
• 專利評估平台
• 忠誠度管理平台

全球生物技術知識產權（IP）貨幣化平台市場規模：依部署模式分類

• 雲
• 現場

全球生物技術知識產權（IP）貨幣化平台市場規模：按應用領域分類

• 專利許可
• 技術轉移
• 投資組合管理
• 版稅管理

全球生物技術知識產權（IP）貨幣化平台市場規模：按最終用戶分類

• 生技公司
• 製藥公司
• 學術和研究機構
• 技術轉移組織

全球生物技術知識產權（IP）貨幣化平台市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• IPwe Inc.
• Ocean Tomo, LLC
• Anaqua, Inc.
• Questel SAS
• Clarivate Plc
• IAM Market
• Cipher Bioscience Ltd.
• IP Pragmatics Limited
• Richardson Oliver Law Group, LLP
• Tynax, Inc.
• TechTransferCentral
• PatSnap Pte. Ltd.
• Gridlogics Technologies Pvt. Ltd.
• Minesoft Ltd.
• IFI CLAIMS Patent Services
• LexisNexis Intellectual Property Solutions
• IP.com
• MaxVal Group, Inc.
• Innovation Asset Group, Inc.
• Inteum Company, LLC

結論與建議

Global Biotech Ip Monetization Platforms Market size was valued at USD 1.06 Billion in 2024 and is poised to grow from USD 1.28 Billion in 2025 to USD 5.64 Billion by 2033, growing at a CAGR of 20.4% during the forecast period (2026-2033).

The global biotech IP monetization platforms market consists of ecosystems that facilitate patent owners, research institutions, and start-ups in licensing or selling their intellectual property using online tools. This market has gained significance due to rising drug development costs, prompting innovators to seek earlier asset value extraction. Initially rooted in technology transfer offices, the sector accelerated with the advent of cloud-based marketplaces that introduced automated valuation methods, simplifying transactions and expanding potential licensee pools. This growth is driven by the convergence of licensing models with cross-border R&D demands, which allows pharmaceutical companies to align therapeutic needs with patented inventions, enhancing deal efficiency. Additionally, AI-driven blockchain solutions are transforming patent management by providing transparent, automated processes, thereby making the market more dynamic and appealing.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biotech Ip Monetization Platforms market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biotech Ip Monetization Platforms Market Segments Analysis

Global biotech ip monetization platforms market is segmented by platform type, deployment mode, application, end user and region. Based on platform type, the market is segmented into Licensing Platforms, IP Marketplace Platforms, Patent Valuation Platforms and Royalty Management Platforms. Based on deployment mode, the market is segmented into Cloud and On-Premises. Based on application, the market is segmented into Patent Licensing, Technology Transfer, Portfolio Management and Royalty Administration. Based on end user, the market is segmented into Biotechnology Companies, Pharmaceutical Companies, Academic & Research Institutions and Technology Transfer Offices. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biotech Ip Monetization Platforms Market

One of the key market drivers for the Global Biotech IP Monetization Platforms Market is the increasing demand for innovative healthcare solutions prompted by growing global health challenges. As biotechnology research evolves, firms face the need to protect their intellectual property (IP) through effective monetization strategies. This pressure to capitalize on groundbreaking discoveries encourages biotech companies to seek robust platforms for licensing, selling, or partnering their patents and technologies. Additionally, the rise of personalized medicine and advancements in genomics and therapeutics further emphasize the necessity of securing revenue-generating opportunities from IP assets, driving the adoption of these platforms.

Restraints in the Global Biotech Ip Monetization Platforms Market

One key market restraint for the Global Biotech IP Monetization Platforms Market is the increasing complexity of intellectual property regulations and compliance requirements. As biotech innovations advance, the legal landscape surrounding patents and intellectual property rights becomes more intricate. Navigating these regulatory frameworks can be time-consuming and costly for companies seeking to monetize their innovations. Additionally, varying international laws and enforcement mechanisms can hinder cross-border transactions, creating uncertainties that may deter investments in biotech projects. This complexity can limit the accessibility and attractiveness of IP monetization platforms, ultimately impacting market growth and participation.

Market Trends of the Global Biotech Ip Monetization Platforms Market

The Global Biotech IP Monetization Platforms market is experiencing a marked shift towards AI-driven portfolio valuation strategies. Biotech companies are leveraging sophisticated artificial intelligence algorithms to enhance the assessment of their patent assets, streamlining the identification of high-value innovations and refining licensing negotiations. These AI tools adeptly analyze intricate scientific literature, track emerging therapeutic modalities, and evaluate market interests, enabling firms to strategically prioritize intellectual property that aligns with future therapeutic trends. Consequently, platform providers incorporating AI analytics are witnessing increased demand from innovators seeking effective monetization pathways and from investors looking for unique pipeline opportunities, thus reshaping the market landscape.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Biotech IP Monetization Platforms Market Size by Platform Type & CAGR (2026-2033)

• Market Overview
• Licensing Platforms
• IP Marketplace Platforms
• Patent Valuation Platforms
• Royalty Management Platforms

Global Biotech IP Monetization Platforms Market Size by Deployment Mode & CAGR (2026-2033)

• Market Overview
• Cloud
• On-Premises

Global Biotech IP Monetization Platforms Market Size by Application & CAGR (2026-2033)

• Market Overview
• Patent Licensing
• Technology Transfer
• Portfolio Management
• Royalty Administration

Global Biotech IP Monetization Platforms Market Size by End User & CAGR (2026-2033)

• Market Overview
• Biotechnology Companies
• Pharmaceutical Companies
• Academic & Research Institutions
• Technology Transfer Offices

Global Biotech IP Monetization Platforms Market Size & CAGR (2026-2033)

• North America (Platform Type, Deployment Mode, Application, End User)
  • US
  • Canada
• Europe (Platform Type, Deployment Mode, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Platform Type, Deployment Mode, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Platform Type, Deployment Mode, Application, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Platform Type, Deployment Mode, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• IPwe Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ocean Tomo, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anaqua, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Questel SAS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clarivate Plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IAM Market
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipher Bioscience Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IP Pragmatics Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Richardson Oliver Law Group, LLP
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tynax, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TechTransferCentral
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PatSnap Pte. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gridlogics Technologies Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Minesoft Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IFI CLAIMS Patent Services
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LexisNexis Intellectual Property Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IP.com
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MaxVal Group, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Innovation Asset Group, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inteum Company, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations